These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 34253268

  • 1. LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model.
    Wießner I, Falchi M, Palhano-Fontes F, Feilding A, Ribeiro S, Tófoli LF.
    Psychol Med; 2023 Mar; 53(4):1151-1165. PubMed ID: 34253268
    [Abstract] [Full Text] [Related]

  • 2. Alterations of consciousness and mystical-type experiences after acute LSD in humans.
    Liechti ME, Dolder PC, Schmid Y.
    Psychopharmacology (Berl); 2017 May; 234(9-10):1499-1510. PubMed ID: 27714429
    [Abstract] [Full Text] [Related]

  • 3. Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response.
    Calder AE, Rausch B, Liechti ME, Holze F, Hasler G.
    J Psychopharmacol; 2024 Oct; 38(10):873-886. PubMed ID: 39302087
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration.
    Avram M, Müller F, Rogg H, Korda A, Andreou C, Holze F, Vizeli P, Ley L, Liechti ME, Borgwardt S.
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Sep; 7(9):885-894. PubMed ID: 35500840
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. LSD enhances suggestibility in healthy volunteers.
    Carhart-Harris RL, Kaelen M, Whalley MG, Bolstridge M, Feilding A, Nutt DJ.
    Psychopharmacology (Berl); 2015 Feb; 232(4):785-94. PubMed ID: 25242255
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.
    Holze F, Gasser P, Müller F, Dolder PC, Liechti ME.
    Biol Psychiatry; 2023 Feb 01; 93(3):215-223. PubMed ID: 36266118
    [Abstract] [Full Text] [Related]

  • 17. Analysis of recreational psychedelic substance use experiences classified by substance.
    Hase A, Erdmann M, Limbach V, Hasler G.
    Psychopharmacology (Berl); 2022 Feb 01; 239(2):643-659. PubMed ID: 35031816
    [Abstract] [Full Text] [Related]

  • 18. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
    Johnson MW, Hendricks PS, Barrett FS, Griffiths RR.
    Pharmacol Ther; 2019 May 01; 197():83-102. PubMed ID: 30521880
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution.
    Tagliazucchi E, Roseman L, Kaelen M, Orban C, Muthukumaraswamy SD, Murphy K, Laufs H, Leech R, McGonigle J, Crossley N, Bullmore E, Williams T, Bolstridge M, Feilding A, Nutt DJ, Carhart-Harris R.
    Curr Biol; 2016 Apr 25; 26(8):1043-50. PubMed ID: 27085214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.